BRIANNA CASAMASSIMA: Open Payments
NPI 1952934630 · VOORHEES, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$435 in 21 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $310 · 2025 $435
Food & beverage: $345Education: $90
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 5 | $158 |
| SHIELD THERAPEUTICS INC | 3 | $65 |
| Evofem Biosciences, Inc. | 3 | $42 |
| Sage Therapeutics, LLC | 2 | $34 |
| ABBVIE INC. | 2 | $33 |
| MILLICENT US INC | 2 | $33 |
| Exact Sciences Corporation | 1 | $23 |
| Organon LLC | 1 | $18 |
| Exeltis, USA Inc. | 1 | $14 |
| Acella Pharmaceuticals, LLC | 1 | $13 |
Products named: Veozah, ACCRUFER, Phexxi, ZURZUVAE, LILETTA, The Cologuard Plus Collection Kit, NEXPLANON, INTRAROSA.
Industry payments across NJ — which companies pay providers there.
